Search

everythinglearnresearchcommunity

for

Search:↓

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

A horse in Brazil with skin and gut issues was diagnosed with a severe disease and had to be euthanized.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

EPDS and MS might share an immune-related cause.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Toxic Shock Syndrome mainly affects menstruating women, can recur, and is linked to staph bacteria, with rapid treatment being crucial.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Correct skin biopsy techniques are crucial to avoid misdiagnosis of skin diseases.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Mutant mice help researchers understand hair growth and related genetic factors.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Asian hair is generally straight and thick, with unique disorders and properties, and more research is needed to understand it fully.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.